Trial Profile
Pharmacokinetic and pharmacodynamic drud-drug interaction between icosapent ethyl and warfarin in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Ethyl eicosapentaenoic acid (Primary) ; Warfarin
- Indications Hypertriglyceridaemia
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Amarin Pharmaceuticals
- 08 Dec 2015 New trial record